BioCentury
ARTICLE | Company News

Takeda sales and marketing update

June 28, 2010 7:00 AM UTC

Takeda's Takeda Pharmaceuticals North America Inc. subsidiary launched ACTOplus met XR extended-release pioglitazone/metformin tablets in the U.S. to treat Type II diabetes. The once-daily fixed-dose...